Clinically Enabled Manufacturing
The NBF has a proven track record of working with our collaborators to develop programs through to Phase I clinical end points. The NBF also provides hands-on training in cleanroom bioprocess operations in a simulated GMP environment.
Scalable up to 200L
NBF has established equipment platforms and process models at each node to enable efficient tech transfer and scale-up from shake flask up to 200L bioreactor scale, offering affordable production services whatever your application or material volume and quality requirements.
Drug Substance to Fill and Finish
Through the Victorian node, the NBF is on track to bring online a new purpose-built cGMP facility beginning in 2023, with 200L mammalian production scale to generate drug substance for bulk fill or for limited (up to 300 vials) drug product final formulation and fill services.
Full QC Release
We take a phase appropriate testing approach for each program to ensure the NBF can support release assays for Quality Assurance-issued Certificates of Analysis through to in-process or for-information-only characterisation results.
The NBF through the NSW node, offers hands-on teaching and training experiences delivering training programs from the Dublin-based National Institute of Bioprocessing Research and Training (NIBRT).